Approval of the protocol for the post-approval study (pas) referenced above. The pas protocol has been submitted to comply with the conditions of approval outlined in our approval order for p170039.
Device | CustomFlex Artificial Iris |
Classification Name | Artificial Iris |
Generic Name | Artificial Iris |
Applicant | Clinical Research Consultants, Inc. |
Date Received | 2018-07-10 |
Decision Date | 2019-09-23 |
PMA | P170039 |
Supplement | S001 |
Product Code | QBT |
Advisory Committee | Ophthalmic |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol - Ode/oir |
Expedited Review | No |
Combination Product | No |
Applicant Address | Clinical Research Consultants, Inc. 3308 Jefferson Avenue, Upper Level cincinnati, OH 45220 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P170039 | | Original Filing |
S003 |
2019-09-25 |
135 Review Track For 30-day Notice |
S002 |
2018-07-19 |
Normal 180 Day Track No User Fee |
S001 |
2018-07-10 |
Normal 180 Day Track No User Fee |
NIH GUDID Devices